BAX vs STVN vs BDX Stock Comparison

Baxter International, Stevanato Group S.p.A and Becton Dickinson Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (STE) Create a free account to keep reading and compare up to 10 companies.
BAX Baxter International Inc
$23.49 0.0% 1M +4.8% 1Y
Market cap
$11.81B
P/E
–
Revenue (TTM)
$11.61B
Div. yield
0.01%
Medical Supplies Healthcare
1 win
STVN Stevanato Group S.p.A.
$20.29 -4.3% 1M -21.4% 1Y
Market cap
$5.30B
P/E
33.7x
Revenue (TTM)
$1.43B
Div. yield
–
Medical Supplies Healthcare
4 wins
BDX Becton Dickinson & Co
$198.32 +8.9% 1M +9.3% 1Y
Market cap
$54.28B
P/E
57.7x
Revenue (TTM)
$23.25B
Div. yield
–
Medical Supplies Healthcare
6 wins

Head to Head

11 decided of 12

Becton Dickinson leads on 6 of the 12 questions below (Becton Dickinson 6, Stevanato Group S.p.A 4, Baxter International 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBAXSTVNBDXLeader
Larger companyMarket capitalisation $11.81B $5.30B $54.28B BDX
Cheaper on earningsLower P/E, profitable companies only -16.3x 33.7x 57.7x STVN
Cheaper on forward earningsLower price / next fiscal year consensus EPS 11.9x 30.7x 15.3x BAX
Faster revenue growthRevenue growth, trailing twelve months +5.3% +14.8% +17.4% BDX
More profitableNet margin, trailing twelve months -6.2% 11.0% 4.0% STVN
Better return on capitalReturn on invested capital -1.4% 7.2% 5.3% STVN
Less leveragedLower net debt / EBITDA 9.0x 1.2x 3.2x STVN
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +4.8% -21.4% +9.3% BDX
Better 5-year returnAnnualised price return, 5 years -21.5%/yr -4.6%/yr -3.7%/yr BDX
Less volatileAnnualised volatility, 1 year 45.1% 45.8% 31.8% BDX
Higher overall scoreMean of the five percentile scores vs peers 44/100 67/100 68/100 BDX

Percentile Scorecard

BAXSTVNBDX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBAXSTVNBDX
Valuation 89 #25 of 227 80 #46 of 227 90 #23 of 227
Growth 14 #187 of 218 58 #92 of 218 48 #114 of 218
Profitability 66 #69 of 202 83 #36 of 202 80 #42 of 202
Financial Health 19 #189 of 233 72 #66 of 233 28 #168 of 233
Shareholder Returns 33 #87 of 130 41 #77 of 130 95 #8 of 130
Overall 44 67 68
  • BAX ranked among 247 companies in Medical Devices and Diagnostics
  • STVN ranked among 247 companies in Medical Devices and Diagnostics
  • BDX ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBAXSTVNBDXSPY
1 month 0.0%-4.3%+8.9% +0.7%
3 months -12.2%+0.4%+19.8% +3.7%
6 months +33.6%+19.4%+33.1% +7.1%
Year to date +22.9%+0.8%+2.2% +12.8%
1 year +4.8%-21.4%+9.3% +11.9%
3 years -26.7%-25.8%-21.0% +85.2%
3 years, per year -9.8%-9.5%-7.6% +22.8%
5 years -70.3%-21.0%-17.2% +67.6%
5 years, per year -21.5%-4.6%-3.7% +10.9%
10 years -50.2%—+18.2% +262.0%
10 years, per year -6.7%—+1.7% +13.7%

Risk

MeasureBAXSTVNBDXSPY
Volatility, 1Y 45.1%45.8%31.8% 12.7%
Downside volatility, 1Y 49.5%44.7%33.1% 12.6%
Beta vs S&P 500, 1Y 1.181.100.33 1.00
Return / volatility, 1Y 0.11-0.470.29 0.94
Max drawdown, 5Y -82.3%-62.2%-50.4% -25.4%
From 52-week high -17.1%-21.4%-5.6% -1.2%
52-week high $28.35$25.80$210.02 $779.14
52-week low $15.80$13.43$140.71 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBAXSTVNBDX
P/E now vs peer median -16.8xmedian 28.7x 35.3xmedian 28.7x 57.9xmedian 28.7x
P/S now vs peer median 1.0xmedian 3.0x 4.3xmedian 3.0x 2.3xmedian 3.0x
EV/EBITDA now vs peer median 25.6xmedian 17.8x 19.0xmedian 17.8x 14.1xmedian 17.8x
P/FCF now vs peer median 10.5xmedian 26.4x 10.4xmedian 26.4x 16.9xmedian 26.4x
P/B now vs peer median 1.9xmedian 2.4x 3.5xmedian 2.4x 2.2xmedian 2.4x
PEG now vs peer median 0.53median 0.99 -131.55median 0.99 -3.97median 0.99

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBAXSTVNBDX
Revenue $11.61B $1.43B $23.25B
Gross profit $3.49B $416.82M $10.91B
Operating income -$221.00M $233.97M $2.48B
Net income -$723.00M $157.06M $941.00M
Free cash flow $1.16B $592.88M $3.20B
R&D $519.00M $29.75M $1.37B
EPS (diluted) $-1.39 $0.58 $3.42
Cash & equivalents $1.98B $89.82M $708.00M
Total debt $8.60B $2.11B $72.81B
Shares (diluted) 520.00M 272.96M 275.16M
Enterprise value $3.69B $4.74B $51.43B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBAXSTVNBDX
P/E -16.8x 35.3x 57.9x
P/FCF 10.5x 10.4x 16.9x
P/Operating cash flow 7.3x 21.2x 13.7x
P/S 1.0x 4.3x 2.3x
P/B 1.9x 3.5x 2.2x
P/Tangible book 4.7x 3.6x 2.3x
EV/EBITDA 25.6x 19.0x 14.1x
EV/EBIT -84.9x 28.0x 28.3x
EV/Revenue 1.6x 4.6x 3.0x
EV/FCF 16.2x 11.0x 21.9x
EV/Operating cash flow 11.3x 22.6x 17.7x
PEG (3Y EPS CAGR) 0.53 -131.55 -3.97

Growth

14 metrics
MetricBAXSTVNBDX
Revenue growth (1Y) 5.3% 14.8% 17.4%
Revenue CAGR (3Y) 0.7% 9.8% 6.9%
Gross profit growth (1Y) -7.1% 19.4% 23.7%
Gross profit CAGR (3Y) -7.7% 6.2% 8.5%
Operating income growth (1Y) -136.3% 17.2% 13.0%
Operating income CAGR (3Y) 4.2% 4.5% 3.3%
Net income growth (1Y) -112.0% 7.5% -40.6%
Net income CAGR (3Y) -31.6% 0.8% -17.3%
EPS growth (1Y) -109.6% 6.7% -38.0%
EPS CAGR (3Y) -31.5% -0.3% -14.6%
Operating cash flow growth (1Y) 97.4% 30.4% 43.5%
Operating cash flow CAGR (3Y) 0.6% 32.9% 14.5%
Free cash flow growth (1Y) 243.5% 17.2% 54.2%
Free cash flow CAGR (3Y) -5.0% 8.0% 22.5%

Profitability

14 metrics
MetricBAXSTVNBDX
Gross margin 30.1% 29.2% 46.9%
EBITDA margin 6.3% 24.1% 21.4%
Operating margin -1.9% 16.4% 10.7%
Pretax margin -1.6% 15.7% 8.4%
Net margin -6.2% 11.0% 4.0%
FCF margin 10.0% 41.5% 13.8%
Operating cash flow margin 14.3% 20.3% 17.0%
Return on equity -11.4% 8.9% 3.9%
Return on assets -3.7% 5.3% 1.9%
Return on invested capital -1.4% 7.2% 5.3%
Return on capital employed -1.4% – 6.0%
Asset turnover 0.6x 0.5x 0.5x
Cash conversion (OCF / net income) -2.3x 1.8x 4.2x
Stock comp / revenue 0.9% – 1.2%

Financial Health

11 metrics
MetricBAXSTVNBDX
Debt / assets 44.3% 17.0% 33.1%
Debt / equity 1.3x 0.3x 0.7x
Net debt / EBITDA 9.0x 1.2x 3.2x
Debt / FCF 7.4x 0.9x 5.2x
Liabilities / assets 66.5% 40.8% 51.9%
Equity / assets 33.5% 59.2% 48.1%
Interest coverage – 14.9x 4.2x
Current ratio 1.8x – 0.9x
Quick ratio 1.0x – 0.3x
Cash ratio 0.5x – 0.1x
Altman Z-score 2.33 – 2.30

Shareholder Returns

7 metrics
MetricBAXSTVNBDX
Dividend yield 0.2% 0.2% 2.1%
Net buyback yield -0.2% – 4.6%
Shareholder yield 0.0% 0.2% 6.7%
Payout ratio (earnings) -14.1% – –
Payout ratio (FCF) 8.8% – –
Dividend growth (1Y) -75.0% – –
Dividend CAGR (3Y) -44.1% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBAXSTVNBDX
Forward P/E 11.9xFY2026 30.7xFY2026 15.3xFY2026
EPS, next fiscal year $1.98FY2026 $0.66FY2026 $12.99FY2026
EPS growth, next FY -10.4%FY2026 +4.8%FY2026 +14.8%FY2026
EPS growth, the year after -3.5% +15.2% -2.9%
Revenue, next fiscal year $11.05BFY2026 $1.46BFY2026 $18.11BFY2026
Revenue growth, next FY -1.7%FY2026 +5.1%FY2026 -17.1%FY2026
Revenue growth, the year after +11.7% +10.0% +11.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBAXSTVNBDX
Held by institutions 100.0% 16.4% 96.1%
Institutions holding 691 126 1,443
Change in shares held, QoQ +5.2% +0.4% +0.6%
Institutions buying 359 61 688
Institutions selling 193 52 544
Buyers to sellers 1.86 1.17 1.26

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BAXSTVNBDX
BAX 1.00 0.17 0.39
STVN 0.17 1.00 0.22
BDX 0.39 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BAX, STVN and BDX?

Becton Dickinson (BDX) is the largest by market capitalisation: Baxter International (BAX) $11.81B, Stevanato Group S.p.A (STVN) $5.30B, Becton Dickinson (BDX) $54.28B.

Which stock is cheaper, BAX, STVN and BDX?

Stevanato Group S.p.A (STVN) trades on the lowest price-to-earnings ratio (Baxter International (BAX) -16.3x, Stevanato Group S.p.A (STVN) 33.7x, Becton Dickinson (BDX) 57.7x). On next year's consensus earnings, Baxter International (BAX) is cheapest (Baxter International (BAX) 11.9x, Stevanato Group S.p.A (STVN) 30.7x, Becton Dickinson (BDX) 15.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Becton Dickinson (BDX) grew revenue fastest over the trailing twelve months: Baxter International (BAX) +5.3%, Stevanato Group S.p.A (STVN) +14.8%, Becton Dickinson (BDX) +17.4%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (Baxter International (BAX) -6.2%, Stevanato Group S.p.A (STVN) 11.0%, Becton Dickinson (BDX) 4.0%). On return on invested capital, Stevanato Group S.p.A (STVN) leads (Baxter International (BAX) -1.4%, Stevanato Group S.p.A (STVN) 7.2%, Becton Dickinson (BDX) 5.3%).

Which stock has performed better?

Over the past year Becton Dickinson (BDX) returned the most: Baxter International (BAX) +4.8%, Stevanato Group S.p.A (STVN) -21.4%, Becton Dickinson (BDX) +9.3%. Over five years, Becton Dickinson (BDX) compounded fastest (Baxter International (BAX) -21.5%/yr, Stevanato Group S.p.A (STVN) -4.6%/yr, Becton Dickinson (BDX) -3.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Baxter International (BAX) 0.01%, Stevanato Group S.p.A (STVN) 0.00%, Becton Dickinson (BDX) 0.00%. Stevanato Group S.p.A (STVN) and Becton Dickinson (BDX) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Becton Dickinson (BDX) has been the steadiest (Baxter International (BAX) 45.1%, Stevanato Group S.p.A (STVN) 45.8%, Becton Dickinson (BDX) 31.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BAX, STVN and BDX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Becton Dickinson (BDX) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.